REQUEST A DEMO
Total
USD $0.00
Search more companies

Alio Medica Sp. z o.o. Sp.J. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Construction of Buildings | Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Real Estate | Offices of Real Estate Agents and Brokers | Real Estate Property Managers | All Other Miscellaneous Schools and Instruction
Full name: Alio Medica Sp. z o.o. Sp.J. Profile Updated: May 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Alio Medica Sp. z o.o. Sp.J. is based in Poland. The head office is in Bydgoszcz. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on March 24, 2021. The company’s latest financial report indicates a net sales revenue increase of 328.89% in 2025. Its’ total assets recorded a negative growth of 97.9%. The net profit margin of Alio Medica Sp. z o.o. Sp.J. increased by 1.29% in 2025.

Headquarters
Ul. Gorzysta 15/1
Bydgoszcz; Kujawsko-Pomorskie; Postal Code: 85-167

Contact Details: Purchase the Alio Medica Sp. z o.o. Sp.J. report to view the information.

Basic Information
Financial Auditors:
Purchase the Alio Medica Sp. z o.o. Sp.J. report to view the information.
Incorporation Date:
March 24, 2021
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Alio Medica Sp. z o.o. Sp.J. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
328.89%
Total Operating Revenue
318.76%
Operating Profit
407.27%
EBITDA
407.27%
Net Profit/Loss for the Period
355.79%
Total Assets
-97.9%
Total Equity
N/A
Operating Profit Margin
4.13%
Net Profit Margin
1.29%
Return on Equity (ROE)
N/A
Quick Ratio
3.41%
Cash Ratio
2.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?